Literature DB >> 9020034

PPAR alpha mediates peroxisome proliferator-induced transcriptional repression of nonperoxisomal gene expression in mouse.

K Motojima1, J M Peters, F J Gonzalez.   

Abstract

The strain difference, peroxisome proliferator specificity and role of PPAR alpha in peroxisome proliferator-induced transcriptional repression of nonperoxisomal transthyretin and alpha2u-globulin genes were examined. The genes were repressed by four peroxisome proliferators in all seven mouse strains tested. The extent of repression was strongly dependent on both the mouse strains and type of proliferator, although the mRNA levels of PPAR alpha and its partner in heterodimerization, RXR alpha were not different. The role of PPAR alpha in repression was confirmed by the finding that PPAR alpha-null mice were not responsive to transcriptional repression. These results indicate that PPAR alpha plays an obligatory role in transcription of various genes, some of which are not related to lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020034     DOI: 10.1006/bbrc.1996.5906

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Analysis of tissue-specific and PPARalpha-dependent induction of FABP gene expression in the mouse liver by an in vivo DNA electroporation method.

Authors:  Kensei Fujishiro; Yuka Fukui; Osamu Sato; Kohei Kawabe; Koichi Seto; Kiyoto Motojima
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

2.  Inhibitory effects of fenofibrate on plasminogen activator inhibitor-1 expression in human endothelial cells.

Authors:  Chunxia Dong; Yu Hu; Huafang Wang; Chunyan Sun; Yadan Wang; Wenjuan He; Xiaoping Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

3.  An epitope-tagging system for studying regulation of the peroxisome proliferator activated receptor alpha (PPAR alpha).

Authors:  J M Owens; J D Tugwood; G G Gibson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1997 Oct-Dec       Impact factor: 2.441

4.  Effects of clofibrate on salt loading-induced hypertension in rats.

Authors:  Antonio Cruz; Isabel Rodríguez-Gómez; Rocío Pérez-Abud; Miguel Ángel Vargas; Rosemary Wangensteen; Andrés Quesada; Antonio Osuna; Juan Manuel Moreno
Journal:  J Biomed Biotechnol       Date:  2010-10-14

Review 5.  High density lipoprotein cholesterol: an evolving target of therapy in the management of cardiovascular disease.

Authors:  Navin K Kapur; Dominique Ashen; Roger S Blumenthal
Journal:  Vasc Health Risk Manag       Date:  2008

6.  The Interaction of FABP with Kapα.

Authors:  Ortal Amber-Vitos; Nataly Kucherenko; Esther Nachliel; Menachem Gutman; Yossi Tsfadia
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.